Company Name, Ticker, Suppliers, else..
STOCKS
HOME
Stock Profile
Company Fundamentals
Financial Results
ENTA's Officers & Directors
Company Descriptions
Charts & Quotes
News
Company Suppliers
Company Competitors
Company Markets Customers
Economic Indicators
INDUSTRIES
Revenue Growth by Industry
Net Income Growth by Industry
Net Margin by Industry
PE by Industry
Total Debt to Equity by Industry
Revenue per Employee by Industry
Return On Assets by Industry
Performance by Industry
Growth Rates by Industry
Profitability by Industry
Valuation by Industry
Financial Strength by Industry
ECONOMY
Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
U.S. International Trade
Factory orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
MARKETS
Stocks
Cryptocurrencies
Sectors & Industries
Commodities
Foreign Exchange
Stocks in 2023
SCREENING
Stock Performance Screening
Profitability Screening
Valuation Screening
Dividend Screening
Financial Strength Screening
Efficiency Screening
Largest Companies
Mgmnt. Effectivness Screening
NEWS
Stock News
Economy News
GLOSSARY
Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
HELP
Company Profile
Enanta Pharmaceuticals Inc News
Enanta Pharmaceuticals Inc's Price to earnings ratio PE
Enanta Pharmaceuticals Inc's Dividend Growth
Enanta Pharmaceuticals Inc Business Description
Enanta Pharmaceuticals Inc Executive Officers
Economic Indicators
Fundamentals
Enanta Pharmaceuticals Inc Growth Rates
Enanta Pharmaceuticals Inc Profitability
Enanta Pharmaceuticals Inc Valuation
Enanta Pharmaceuticals Inc Management Effectiveness
Enanta Pharmaceuticals Inc Financial Strength
Enanta Pharmaceuticals Inc Efficiency
Enanta Pharmaceuticals Inc Dividend
Financials
Enanta Pharmaceuticals Inc Business Segments
Enanta Pharmaceuticals Inc Income Statement
Enanta Pharmaceuticals Inc Balance Sheets
Enanta Pharmaceuticals Inc Cash Flow Statement
Enanta Pharmaceuticals Inc Geographic Information
Suppliers
Enanta Pharmaceuticals Inc Suppliers Performance
ENTA Suppliers Stock Performance
ENTA Suppliers Growth Rates
ENTA Suppliers Data
ENTA Suppliers Efficiency
ENTA Suppliers Management Effectiveness
ENTA Suppliers Valuation
ENTA Suppliers by Companys' Segments
Competition
Competition by Companys' Segments
Enanta Pharmaceuticals Inc Market Share
Enanta Pharmaceuticals Inc Competition Performance
Enanta Pharmaceuticals Inc Competitors Results
ENTA Competitors Stock Performance
ENTA Competitors Growth Rates
ENTA Workforce Efficiency at the Competitors
ENTA Competitors Efficiency
ENTA Competitors Management Effectiveness
ENTA Competitors Valuation
Customers & Markets
Enanta Pharmaceuticals Inc Customers Demand
ENTA Customers Expenditure Growth Rates
ENTA Customers Performance
ENTA Customers Stock Performance
ENTA Customers Growth Rates
ENTA Workforce Efficiency at the Customers
ENTA Customers Efficiency
ENTA Customers Management Effectiveness
ENTA Customers Valuation
ENTA Customers by Companys' Segments
Charts & Quotes
Enanta Pharmaceuticals Inc Comparison Charts
ENTA OHLC Charts
ENTA's Tehnical Upper Indicators
ENTA's Tehnical Lower Indicators
ENTA's Weekly Charts
ENTA's Monthly Charts
Enanta Pharmaceuticals Inc's Profile
Company Charts and Quotes
Enanta Pharmaceuticals Inc News
Enanta Pharmaceuticals Inc's Business Segments
Enanta Pharmaceuticals Inc's Income Statement
Enanta Pharmaceuticals Inc's Balance Sheets
Enanta Pharmaceuticals Inc's Cash Flow Statement
Enanta Pharmaceuticals Inc's Profitability
Enanta Pharmaceuticals Inc's Financials
Enanta Pharmaceuticals Inc's PE Ratio TTM
Enanta Pharmaceuticals Inc's Suppliers
Enanta Pharmaceuticals Inc's Competitors
Enanta Pharmaceuticals Inc's Markets & Customers
Enanta Pharmaceuticals Inc's Market Share
ENTA's Suppliers Efficiency
ENTA's Competitors Stock Performance
ENTA's Charts ADX
Enanta Pharmaceuticals Inc's Customers Stock Performance
Economic Indicators
Total Debt to Equity by Industry
Profitability Screening
Markets at a Glance
Stocks
Cryptocurrencies
Sectors & Industries
Commodities
Foreign Exchange
Stocks in 2023
Retail Inventories
News
Economy News
Stock News
About Us
At a Glance
Growth Rates
• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• F. Cash Flow Y/Y Annual
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
Enanta Pharmaceuticals Inc
(
ENTA
)
Other Ticker:
Sector
•
Healthcare
Industry
•
Major Pharmaceutical Preparations
Industry
•
Major Pharmaceutical Preparations
Sector
•
Healthcare
Enanta Pharmaceuticals Inc's Yearly Free Cash Flow Growth 5 Years
Select the Comparisons :
None ▼
Growth Rates
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
Select the Ratio:
Annual Free Cash Flow Annual Growth Rates Y/Y▼
Revenue Y/Y
Op. Income Y/Y
Income from Cont. Operations Y/Y
Net Income Y/Y
Effective Tax Rate
Eps Cop. Y/Y
Eps Net Y/Y
Free Cash Flow Y/Y
Cash Flow Y/Y
Capex Y/Y
Gross Margin
EBITDA Margin
Operating Margin
Net Margin
Pre-Tax Margin
Free Cash Flow Margin
Cash Flow Margin
P/E Ratio TTM
P/S Ratio TTM
P/CF Ratio TTM
P/FCF Ratio TTM
Price to Book MRQ
Price to Tangible Book
ROA Quarterly
ROI Quarterly
ROE Quarterly
Quick Ratio
Quick Ratio TTM
Working Capital
Working Capital TTM
Long Term Debt to Equity
Long Term Debt to Equity TTM
Debt to Equity
Debt to Equity TTM
Leverage Ratio
Leverage Ratio TTM
Tangible Leverage Ratio
Interest Coverage
Debt Coverage
Working Capital Per Revenue
Sales per Employee
Income per Employee
Inventory to Sales
Inventory Turnover
Asset Turnover
Receivables Turnover
Dividend Growth
Dividend Payout
Cumulative Payout
Annual Dividend Payout
Revenue Annual Growth
Operating Income Annual Growth
Income from Continued Operations Annual Growth
Net Income Annual Growth
Eps Continued Operations Annual Growth
Eps Net Annual Growth
Free Cash Flow Annual Growth
Cash Flow Annual Growth
Capex Annual Growth
None ▼
Growth Rates
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
Annual Free Cash Flow Annual Growth Rates Y/Y▼
Revenue Y/Y
Op. Income Y/Y
Income from Cont. Operations Y/Y
Net Income Y/Y
Effective Tax Rate
Eps Cop. Y/Y
Eps Net Y/Y
Free Cash Flow Y/Y
Cash Flow Y/Y
Capex Y/Y
Gross Margin
EBITDA Margin
Operating Margin
Net Margin
Pre-Tax Margin
Free Cash Flow Margin
Cash Flow Margin
P/E Ratio TTM
P/S Ratio TTM
P/CF Ratio TTM
P/FCF Ratio TTM
Price to Book MRQ
Price to Tangible Book
ROA Quarterly
ROI Quarterly
ROE Quarterly
Quick Ratio
Quick Ratio TTM
Working Capital
Working Capital TTM
Long Term Debt to Equity
Long Term Debt to Equity TTM
Debt to Equity
Debt to Equity TTM
Leverage Ratio
Leverage Ratio TTM
Tangible Leverage Ratio
Interest Coverage
Debt Coverage
Working Capital Per Revenue
Sales per Employee
Income per Employee
Inventory to Sales
Inventory Turnover
Asset Turnover
Receivables Turnover
Dividend Growth
Dividend Payout
Cumulative Payout
Annual Dividend Payout
Revenue Annual Growth
Operating Income Annual Growth
Income from Continued Operations Annual Growth
Net Income Annual Growth
Eps Continued Operations Annual Growth
Eps Net Annual Growth
Free Cash Flow Annual Growth
Cash Flow Annual Growth
Capex Annual Growth
ENTA Annual Free Cash Flow Growth
2023
2022
2021
2020
2019
Y / Y Annual Free Cash Flow Change
-
-
-
-91.45 %
151.54 %
Annual Free Cash Flow (in millions $)
$-112.21
$-86.91
$-70.75
$5.64
$66.00
ENTA Company Profile
>>
Back to ENTA Fundamentals at a Glance
>>
Back to ENTA Growth Comparisons
Annual Free Cash Flow Growth Comment
Enanta Pharmaceuticals Inc
realized free cash outflow.
Enanta Pharmaceuticals Inc Annual Income Statement
You need to upgrade your Flash Player
Companies with similar 2023 Annual Free Cash Flow within Healthcare Sector
Y/Y Free Cash Flow Growth %
2023 Annual Free Cash Flow
Hologic Inc
-53.32 %
$ 959.400 millions
Vir Biotechnology Inc